PCN378 PHARMACOECONOMIC ANALYSIS OF ATEZOLIZUMAB PLUS NAB-PACLITAXEL IN THE TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER

Autor:	M. Proskurin, Y. Balykina, A. S. Kolbin, I. Velum
Rok vydání:	2019
Předmět:	Oncology medicine.medical_specialty Atezolizumab business.industry Health Policy Internal medicine Public Health Environmental and Occupational Health medicine business Triple-negative breast cancer Nab-paclitaxel
Zdroj:	Value in Health. 22:S510
ISSN:	1098-3015
DOI:	10.1016/j.jval.2019.09.573
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f162e0f9a2c4c50f4fa2177a8ba19ea2 https://doi.org/10.1016/j.jval.2019.09.573 Zobrazit plný text záznamu Full Text from ScienceDirect